MANILA, Philippines — The Food and Drug Administration (FDA) has issued an advisory ordering the recall of a chemotherapy injectable found to be contaminated with bacteria that cause fatal infections.

Accord Healthcare, a London-based drugmaker, resumed manufacturing of two methotrexate solutions, according to a Nov. 7 update from the FDA. By March, the American Society of Health-System Pharmacists ...

Eli Lilly and Incyte’s rheumatoid arthritis (RA) therapy baricitinib has outperformed methotrexate in a phase III clinical trial, the third of four studies in its pivotal trials programme. Top-line ...

Antares Pharma, Inc. announced that the first patient has been dosed in a clinical study evaluating the Vibex MTX product which is being developed for the treatment of rheumatoid arthritis. The ...

The shortage of pediatric cancer drugs is a growing concern for families and healthcare providers, with critical medications, like injectable methotrexate and leucovrin, increasingly hard to obtain ...